The aim of our study was to expand the results of our previous study to clarify the prevalence and clinical relevance of PTEN deletions, especially in muscle‐invasive urothelial bladder carcinomas, and to examine the relationship of PTEN deletions with alterations of p16 and p53 in a large multi‐center study. Here, TP53 is linked to bladder transitional cell carcinoma.